Savara Inc. (SVRA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Savara Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.02
+3.29% today
Market cap
$999M
Overall quality
—
Kronos AI 30-day
+13.7%
8 of 8 simulated paths end higher
Savara Inc. (SVRA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $999M. It trades at $5.02, up 3.29% today. 5 analysts' average target of $11.33 implies +125.7% from today's price. Kronos AI's 30-day forecast is +13.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.33 |
| Low – high | $9.00 – $16.00 |
| Analysts | 5 |
| Upside to average | +125.7% |
Kronos AI 30-day forecast
| Expected close | $5.52 (+13.7%) |
| Likely range | +4.7% … +23.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.